FEops HEARTguideTM vs ClearRead CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by FEops
VS
by Riverain Technologies

AI Verdict

FEops HEARTguideTM specializes in AI-driven predictive simulations for structural heart procedure planning, optimizing device sizing and positioning. ClearRead CT, conversely, focuses on enhancing diagnostic accuracy in CT scans, specifically for pulmonary nodule detection and coronary artery calcification analysis. While both utilize AI in cardiology and radiology, their primary applications address distinct clinical workflows: pre-procedural planning versus diagnostic interpretation.

Choose FEops HEARTguideTM if…

Choose FEops HEARTguideTM if your primary need is to meticulously plan complex structural heart interventions like TAVI or LAAO. This platform excels at providing predictive simulations and patient-specific anatomical insights, allowing clinicians to optimize device sizing and positioning before the actual procedure. It's ideal for reducing procedural risks and improving outcomes in intricate cardiac cases.

View FEops HEARTguideTM →

Choose ClearRead CT if…

Choose ClearRead CT if your priority is to enhance the speed and accuracy of pulmonary nodule detection and coronary artery calcification analysis from CT scans. This AI suite leverages patented vessel suppression technology to improve diagnostic confidence and significantly reduce reading times for radiologists. It is particularly well-suited for high-volume radiology departments seeking to streamline workflows and improve early disease detection.

View ClearRead CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature FEops HEARTguideTM ClearRead CT
Pricing Unknown Contact for pricing
Deployment Cloud-based On-premise (stand-alone server, virtual machine) and Cloud
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FEops HEARTguideTM

FEops HEARTguideTM offers a cloud-based platform with an interactive 2D and 3D viewer, allowing access from anywhere at any time for detailed analysis. This flexibility and direct user interaction with complex anatomical models for procedure planning suggest a highly user-centric experience. While ClearRead CT focuses on workflow integration and efficiency, Tool A's direct interactive capabilities provide a slight edge in direct usability for its specialized function.

Clinical Value

ClearRead CT

ClearRead CT provides a quantifiable and significant clinical benefit with a '29% reduction in missed actionable nodules' and improved detection accuracy. This directly impacts early disease detection and patient outcomes. While FEops HEARTguideTM's predictive simulations are highly valuable for optimizing procedural success, Tool B's explicit and measurable improvement in diagnostic accuracy presents a stronger, more direct claim to clinical value.

Pricing & Value

Tie

Both tools have opaque pricing models, requiring direct contact with the vendor for details. Without any publicly disclosed pricing information for either product, it is impossible to conduct a meaningful comparison of their pricing or assess their relative value propositions.

Enterprise Readiness

FEops HEARTguideTM

FEops HEARTguideTM explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), providing clear transparency for enterprise adoption. While ClearRead CT indicates it 'likely' has a BAA and is HIPAA compliant due to its operation with institutions like the VA, Tool A's direct affirmation offers greater certainty for enterprise-level compliance and integration.

Innovation

FEops HEARTguideTM

FEops HEARTguideTM leverages 'digital twin' technology and 'predictive simulations' for patient-specific device-anatomy interaction in structural heart procedures. This application represents a cutting-edge approach to personalized medicine and pre-procedural optimization. While ClearRead CT features innovative 'Patented Vessel Suppression' and 'Automated Nodule Tracking', the 'digital twin' concept for proactive intervention planning is a more profound innovation.

Support & Docs

Tie

Neither the provided structured facts nor a general web search yielded specific details regarding the depth, availability, or quality of support and documentation for either FEops HEARTguideTM or ClearRead CT. Both companies mention general customer support and training, but lack specific information to differentiate them.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature FEops HEARTguideTM ClearRead CT
Name FEops HEARTguideTM ClearRead CT
Company FEops nv RIVERAIN TECHNOLOGIES
Description FEops HEARTguideu2122 is a cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO. ClearRead CT is an FDA-cleared AI suite by Riverain Technologies for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. It improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows through advanced AI and vessel suppression technology.
Key Features Predictive simulation technology for device-anatomy interaction; AI-based anatomical measurements from CT scans; Cloud-based platform with access from anywhere at any time; DICOM interface for easy integration into clinical workflow; Semi-automatic and manual measurement options for anatomical landmarks; Interactive 2D and 3D viewer for detailed analysis; Segmentation of cardiovascular structures; Visualization and image reconstruction techniques (2D review, MPR) Pulmonary Nodule Detection (solid, part-solid, ground glass); Patented Vessel Suppression (Clear Visual Intelligence); Nodule Characterization and Measurement (volume, diameter, location, type, depth); Automated Nodule Tracking and Comparison to Prior Exams; Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs); Reduced Reading Time (up to 36%); Improved Detection Accuracy (29% reduction in missed actionable nodules); Seamless PACS Integration / Vendor-neutral processing
Specialties Cardiology, Cardiothoracic Surgery, Radiology Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring FEops HEARTguideTM and ClearRead CT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

FEops HEARTguideu2122 is a cloud-based AI and digital twin platform designed for structural heart procedure planning, specifically optimizing device sizing and positioning for interventions like TAVI and LAAO. In contrast, ClearRead CT is an AI suite focused on cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans.
FEops HEARTguideu2122 provides predictive simulations for device-anatomy interaction, AI-based anatomical measurements from CT scans, and segmentation of cardiovascular structures. ClearRead CT offers AI for pulmonary nodule detection (including characterization, measurement, and automated tracking) and coronary artery calcification scoring, utilizing patented vessel suppression technology.
FEops HEARTguideu2122 features a DICOM interface for easy integration into clinical workflows. ClearRead CT offers seamless PACS integration and vendor-neutral processing, with its output provided in DICOM format.
FEops HEARTguideu2122 operates on a service-based business model where clinicians provide input data, and FEops prepares and delivers the analysis results. ClearRead CT functions as an AI suite that processes CT scans, with pre-processed CAD detection results automatically available on PACS for review.
FEops HEARTguideu2122 primarily targets Cardiology, Cardiothoracic Surgery, and Radiology. ClearRead CT is designed for use across Cardiology, Pulmonology, and Radiology specialties.
AI Tool Finder
AI-powered search. Results may not be comprehensive.